1275 related articles for article (PubMed ID: 17009270)
41. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest.
Mentzelopoulos SD; Zakynthinos SG; Tzoufi M; Katsios N; Papastylianou A; Gkisioti S; Stathopoulos A; Kollintza A; Stamataki E; Roussos C
Arch Intern Med; 2009 Jan; 169(1):15-24. PubMed ID: 19139319
[TBL] [Abstract][Full Text] [Related]
42. Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group.
Gross V; Andus T; Fischbach W; Weber A; Gierend M; Hartmann F; Schölmerich J
Z Gastroenterol; 1995 Oct; 33(10):581-4. PubMed ID: 7502549
[TBL] [Abstract][Full Text] [Related]
43. Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial.
Seror R; Baron G; Hachulla E; Debandt M; Larroche C; Puéchal X; Maurier F; de Wazieres B; Quéméneur T; Ravaud P; Mariette X
Ann Rheum Dis; 2014 Dec; 73(12):2074-81. PubMed ID: 23897775
[TBL] [Abstract][Full Text] [Related]
44. [The bane of giant cell arteritis from an ophthalmological viewpoint].
Meli B; Landau K; Gloor BP
Schweiz Med Wochenschr; 1996 Oct; 126(43):1821-8. PubMed ID: 9005521
[TBL] [Abstract][Full Text] [Related]
45. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial.
Burmester GR; Buttgereit F; Bernasconi C; Álvaro-Gracia JM; Castro N; Dougados M; Gabay C; van Laar JM; Nebesky JM; Pethoe-Schramm A; Salvarani C; Donath MY; John MR;
Lancet; 2020 Jul; 396(10246):267-276. PubMed ID: 32711802
[TBL] [Abstract][Full Text] [Related]
46. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
[TBL] [Abstract][Full Text] [Related]
47. [Intravenous high-dose methylprednisolone efficacy for treatment of idiopathic thrombocytopenic purpura in adults].
Visser R; Zweegman S; Ossenkoppele GJ; Huijgens PC
Ned Tijdschr Geneeskd; 1999 Oct; 143(41):2053-7. PubMed ID: 10560547
[TBL] [Abstract][Full Text] [Related]
48. Flares in lupus: Outcome Assessment Trial (FLOAT), a comparison between oral methylprednisolone and intramuscular triamcinolone.
Danowski A; Magder L; Petri M
J Rheumatol; 2006 Jan; 33(1):57-60. PubMed ID: 16395750
[TBL] [Abstract][Full Text] [Related]
49. Improving therapeutic options for patients with giant cell arteritis.
Pipitone N; Salvarani C
Curr Opin Rheumatol; 2008 Jan; 20(1):17-22. PubMed ID: 18281852
[TBL] [Abstract][Full Text] [Related]
50. Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.
Samson M; Devilliers H; Ly KH; Maurier F; Bienvenu B; Terrier B; Charles P; Guillevin L; Besancenot JF; Liozon E; Fauchais AL; Loffroy R; Binquet C; Audia S; Seror R; Mariette X; Bonnotte B
Eur J Intern Med; 2018 Nov; 57():96-104. PubMed ID: 30054122
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
[TBL] [Abstract][Full Text] [Related]
52. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
53. Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al.
Spiera RF; Kupersmith M; Paget S; Spiera H
Arthritis Rheum; 2003 Apr; 48(4):1159-60; author reply 1160-1. PubMed ID: 12687562
[No Abstract] [Full Text] [Related]
54. Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor alpha and interleukin-6) in the long-term followup of patients with giant cell arteritis.
García-Martínez A; Hernández-Rodríguez J; Espígol-Frigolé G; Prieto-González S; Butjosa M; Segarra M; Lozano E; Cid MC
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):835-41. PubMed ID: 20535794
[TBL] [Abstract][Full Text] [Related]
55. Effectiveness and safety of medium-dose prednisone in giant cell arteritis: a retrospective cohort study of 103 patients.
Les I; Pijoán JI; Rodríguez-Álvarez R; Ruiz-Irastorza G; Martínez-Berriotxoa A
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-90-7. PubMed ID: 26016756
[TBL] [Abstract][Full Text] [Related]
56. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ;
Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164
[TBL] [Abstract][Full Text] [Related]
57. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.
Targan SR; Feagan BG; Fedorak RN; Lashner BA; Panaccione R; Present DH; Spehlmann ME; Rutgeerts PJ; Tulassay Z; Volfova M; Wolf DC; Hernandez C; Bornstein J; Sandborn WJ;
Gastroenterology; 2007 May; 132(5):1672-83. PubMed ID: 17484865
[TBL] [Abstract][Full Text] [Related]
58. Benefit of high-dose intravenous methylprednisolone as induction therapy for giant cell arteritis: comment on the article by Mazlumzadeh et al.
Arashvand K
Arthritis Rheum; 2007 May; 56(5):1722; author reply 1723-4. PubMed ID: 17469170
[No Abstract] [Full Text] [Related]
59. Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al.
Jover JA; Hernández-Garcia C; Morado IC; Vargas E; Bañares A; Fernandez-Gutierrez B
Arthritis Rheum; 2003 Apr; 48(4):1158-9. PubMed ID: 12687561
[No Abstract] [Full Text] [Related]
60. Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens.
Di Munno O; Imbimbo B; Mazzantini M; Milani S; Occhipinti G; Pasero G
J Rheumatol; 1995 Aug; 22(8):1492-8. PubMed ID: 7473472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
